EUTM file information



December 15, 2006

Trademark Summary

The trademark application ZAFIANT was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on June 18, 2007, and it was registered by office on January 3, 2008 without any oppositions.

The application was filed in English (Italian was selected as the second language).

The renewal of the trademark was recorded by the office on October 15, 2017.

of the trademark registration was recorded on October 15, 2017.

Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine diseases and disorders and gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive system diseases and disorders, sexual dysfunction, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders
    2. Pharmaceutical preparations for the prevention of diabetes
    3. Antipsychotic agents
    4. And antidepressants
    5. Pharmaceutical preparations.